Concepedia

Rina Sor

RS

4

Publications

512

Citations

4

H-Index

2022

Active since

Affiliations

University of Pennsylvania(Current)

Revolution Medicines (United States)

Parker Institute for Cancer Immunotherapy

Brigham and Women's Hospital

Columbia University

Rina Sor is an author at University of Pennsylvania.

ORCID

Publications per year

2022–2025

4

Publications

4

Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic Cancer

Samantha B. Kemp, Noah Cheng, Nune Markosyan et al. · Cancer Discovery · 2022 · 329 citations · Full text

Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

Urszula N. Wasko, Jingjing Jiang, Tanner C. Dalton et al. · Nature · 2024 · 150 citations · Full text

T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Models of Pancreatic Ductal Adenocarcinoma

Margo Orlen, William P. Vostrejs, Rina Sor et al. · Cancer Discovery · 2025 · 23 citations · Full text

Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinoma

Urszula N. Wasko, Jingjing Jiang, Alvaro Curiel-Garcia et al. · 2023 · 10 citations · Full text

Rows per page

1–4 of 4